128 related articles for article (PubMed ID: 27939375)
1. Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot-Binding Peptide With Interferon Gamma for Cancer Gene Therapy.
Ando M; Fujimoto M; Takahashi Y; Nishikawa M; Hamana A; Takakura Y
J Pharm Sci; 2017 Mar; 106(3):892-897. PubMed ID: 27939375
[TBL] [Abstract][Full Text] [Related]
2. Gene delivery of albumin binding peptide-interferon-gamma fusion protein with improved pharmacokinetic properties and sustained biological activity.
Miyakawa N; Nishikawa M; Takahashi Y; Ando M; Misaka M; Watanabe Y; Takakura Y
J Pharm Sci; 2013 Sep; 102(9):3110-8. PubMed ID: 23463584
[TBL] [Abstract][Full Text] [Related]
3. Prolonged circulation half-life of interferon γ activity by gene delivery of interferon γ-serum albumin fusion protein in mice.
Miyakawa N; Nishikawa M; Takahashi Y; Ando M; Misaka M; Watanabe Y; Takakura Y
J Pharm Sci; 2011 Jun; 100(6):2350-7. PubMed ID: 21246562
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.
Huang Z; Song Y; Pang Z; Zhang B; Yang H; Shi H; Chen J; Gong H; Qian J; Ge J
Int J Nanomedicine; 2017; 12():3023-3036. PubMed ID: 28442910
[TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
[TBL] [Abstract][Full Text] [Related]
6. Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector.
Wu J; Xiao X; Jia H; Chen J; Zhu Y; Zhao P; Lin H; Huang W
BMC Cancer; 2009 Feb; 9():55. PubMed ID: 19216804
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms.
Curnis F; Gasparri A; Sacchi A; Cattaneo A; Magni F; Corti A
Cancer Res; 2005 Apr; 65(7):2906-13. PubMed ID: 15805293
[TBL] [Abstract][Full Text] [Related]
8. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
9. [Control of spatiotemporal distribution of interferon γ by genetically fusing functional peptides].
Ando M; Takahashi Y; Nishikawa M; Takakura Y
Yakugaku Zasshi; 2012; 132(12):1399-406. PubMed ID: 23208047
[TBL] [Abstract][Full Text] [Related]
10. Modification with CREKA Improves Cell Retention in a Rat Model of Myocardial Ischemia Reperfusion.
Chen J; Song Y; Huang Z; Zhang N; Xie X; Liu X; Yang H; Wang Q; Li M; Li Q; Gong H; Qian J; Pang Z; Ge J
Stem Cells; 2019 May; 37(5):663-676. PubMed ID: 30779865
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma is recognised by importin alpha/beta: enhanced nuclear localising and transactivation activities of an interferon gamma mimetic.
Fulcher AJ; Ahmed CM; Noon-Song EN; Kwan RY; Subramaniam PS; Johnson HM; Jans DA
FEBS Lett; 2008 May; 582(11):1569-74. PubMed ID: 18405666
[TBL] [Abstract][Full Text] [Related]
12. Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction.
Shi Q; Zhang Y; Liu S; Liu G; Xu J; Zhao X; Anderson GJ; Nie G; Li S
Biochem Pharmacol; 2018 Oct; 156():501-510. PubMed ID: 30222966
[TBL] [Abstract][Full Text] [Related]
13. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma.
Chung EJ; Cheng Y; Morshed R; Nord K; Han Y; Wegscheid ML; Auffinger B; Wainwright DA; Lesniak MS; Tirrell MV
Biomaterials; 2014 Jan; 35(4):1249-56. PubMed ID: 24211079
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.
Tan L; Han S; Ding S; Xiao W; Ding Y; Qian L; Wang C; Gong W
Int J Nanomedicine; 2017; 12():3095-3107. PubMed ID: 28450784
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
Chang Y; Prud'homme GJ
J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
[TBL] [Abstract][Full Text] [Related]
16. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
17. Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor.
Zhang B; Wang H; Shen S; She X; Shi W; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2016 Feb; 79():46-55. PubMed ID: 26695116
[TBL] [Abstract][Full Text] [Related]
18. Construction, expression and characterization of a fusion protein HBscFv-IFNγ in Komagatella (Pichia) pastoris X33.
Liang MH; Zhou SS; Jiang JG
Enzyme Microb Technol; 2017 Jul; 102():74-81. PubMed ID: 28465064
[TBL] [Abstract][Full Text] [Related]
19. The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.
Hemmerle T; Neri D
Cancer Immunol Res; 2014 Jun; 2(6):559-67. PubMed ID: 24795141
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.
Wu CM; Li XY; Huang TH
World J Gastroenterol; 2004 Oct; 10(20):3011-5. PubMed ID: 15378784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
